Antimicrobial Susceptibility and Selection of Resistance

Size: px
Start display at page:

Download "Antimicrobial Susceptibility and Selection of Resistance"

Transcription

1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1978, p /78/14-353$2./ Copyright 1978 American Society for Microbiology Vol. 14, No. 3 Printed in U.S.A. Antimicrobial Susceptibility and Selection of Resistance Among Staphylococcus epidermidis Isolates Recovered from Patients with Infections of Indwelling Foreign Devices GORDON L. ARCHER Division of Infectious Diseases, Department ofinternal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia Received for publication 31 March 1978 Twenty-seven isolates of Staphylococcus epidermidis from patients with prosthetic valve endocarditis or infected cerebrospinal fluid shunts were examined for susceptibility to antimicrobial agents. Subpopulations resistant to 2 and 1 ttg of methicillin per ml were present in 63% of the isolates (methicillin-resistant isolates). Subpopulations resistant to 2 jig of nafcillin and cephalothin per ml were found in every methicillin-resistant isolate but with frequencies (1-5 ±.5 and 1-64 *.9, respectively) which were not always detectable by susceptibility testing. Resistance to '1.6 jig of penicillin per ml was found in 8% of isolates. Cephalothin, cefazolin, and cefamandole were more active than cefoxitin or cephradine, and gentamicin was more active than tobramycin or amikacin; rifampin was the single most active agent against all isolates. There was no difference in susceptibility between prosthetic valve endocarditis and cerebrospinal fluid shunt infection isolates. Among methicillin-resistant isolates, the phenotypic expression of resistance to methicillin or nafcillin but not to cephalothin could be enhanced by 48 h of incubation with each drug. Isolates containing no methicillin-resistant subpopulations were killed by incubation with methicillin, nafcillin, or cephalothin. High-level resistance to rifampin emerged in both methicillin-resistant and methicillin-sensitive isolates after 8 to 24 h of incubation with this drug. The presence or absence of antibiotic-resistant subpopulations among S. epidermidis isolates and their selection during treatment should be considered when therapy is devised. Staphylococcus epidermidis is one of the most common organisms causing infections of indwelling artificial devices, particularly prosthetic heart valves and cerebrospinal fluid (CSF) shunts (5, 14). Infections of these devices are characteristically difficult to cure with antibiotics alone. Studies have suggested that many S. epidermidis isolates recovered from patients with these infections are resistant to one or more antistaphylococcal antibiotics (9, 16), but no attempt has been made to characterize resistance patterns among these isolates. Investigators who have reported the antimicrobial susceptibilities of large numbers of S. epidermidis isolates have tested organisms recovered from clinical laboratories; many of these isolates may have been contaminants from patient skin (3, 12). We have obtained 27 S. epidermidis isolates from 6 different geographical areas. These isolates were initially recovered on multiple occasions from blood, CSF, or tissue in patients with documented prosthetic valve endocarditis (PVE) or infected CSF shunts. We report the antimicrobial susceptibility and the selection of antibiotic resistance among these isolates. MATERIALS AND METHODS Microorganisms. S. epidermidis isolates from documented infections were obtained from the following institutions and investigators: Medical College of Virginia (G. Archer and R. J. Duma), University of Virginia School of Medicine (M. Sande), Massachusetts General Hospital and Harvard University School of Medicine (A. W. Karchmer), University of Michigan Medical Center (F. R. Fekety, Jr.), University of Alabama Medical School (W. Dismukes), and Stanford University School of Medicine (R. McLeod). Twenty of the isolates were from the blood or perivalvular tissue of patients with PVE, and seven were from the blood or CSF of patients with infections of CSF shunts. Organisms were identified as S. epidernidis by their ability to ferment glucose, their failure to coagulate rabbit plasma, and their inability to use mannitol either aerobically or anaerobically. Of the 27 isolates tested, 13 were typable by specific S. epidermidis typing phages (G. Parisi, University of Missouri School of Medicine). 353 Downloaded from on April 26, 218 by guest

2 354 NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNARCHER Antimicrobial susceptibility testing. For each isolate, minimum inhibitory concentrations (MICs) and miniimum bactericidal concentrations (MBCs) were determined in triplicate by the,*crotiter method with an inoculum size of 15 colony-f6oirminiimigiuts (CFU) per ml, using Mueller-Hinton broth (Baltimore Biological Laboratory [BBL], Cockeysville, Md.) as the diluent. Each MIC was read after both 24 and 48 h of incubation at 37C. Subculturine of wells to Mueller-Hinton agar (BBL) for determination of the MBC was accomplished bvthe use of a replicating ievice which delivered.15 ml on stil prongs. There was a 95% agreement between results obtained by using the replicator and a calibrated.1- ml wire loop. The MBC was read as the lowest dilution yielding no growth on subculture after 24 h of incubation. Susceptibility of the organisms to the following antimicrobial agents was determined: penicillin G potassium (Eli Lilly & Co., Indianapolis, Ind.), sodium nafcillin (Wyeth Laboratories, Philadelphia, Pa.), sodium methicillin (Bristol Laboratories, Syracuse, N.Y.), sodium oxacillin (Bristol), cephalothin sodium (Eli Lilly), cefazolin sodium (Eli Lilly), cefamandole lithium (Eli Lilly), sodium cefoxitin (Merck, Sharp, & Dohme, West Point, Pa.), cephradine (E. R. Squibb and Sons, Princeton, N.J.), vancomycin hydrochloride (Eli Lilly), gentamicin sulfate (Schering Laboratories, Bloomfield, N.J.), tobramycin sulfate (Eli Lilly), amikacin base (Bristol), streptomycin sulfate (Eli Lilly), rifampin (Dow Chemical Co. Indianapolis, Ind.), 7- chloro-7-deoxylincomycin (The Upjohn Co., Kalamazoo, Mich.), erythromycin (Eli Lilly), and sulfamethoxasole-trimethoprim (Burroughs Wellcome Co., Research Triangle Park, N.C.). The susceptibility of isolates to the combination of sulfamethoxasole and trimethoprim was determined in Mueller-Hinton broth supplemented with 9 U of thymidine phosphorylase per ml, kindly provided by S. R. M. Bushby, Burroughs Welcome Co. The MICs and MBCs were expressed as the total activity of the two drugs mixed in a ratio of 19 (sulfamethoxasole) to 1 (trimethoprim). The susceptibility of isolates to cephalothin and nafcillin was further tested in duplicate in plastic tubes (12 by 75 mm; Falcon Plastics, Oxnard, Calif.), using the same media as employed in microtiter testing and an inoculum size of 5 x 15 CFU/ml. Subculture of clear tubes to solid agar was done with a.1-ml wire loop; the MBC was read as that dilution yielding no growth. The MICs and MBCs of nafcillin, methicillin, and cephalothin for all isolates were also determined by microtiter dilution with incubation at,lotk3ands 37Cin brot. containing 5% NaCl. Determination of resistant subpopulations. Four or five colonies of each isolate were picked from agar and incubated overnight at 37 C in Mueller-Hinton broth with shaking. The number of CFU in the overnight cultures was determined by serial dilution resistance was maximized to 1i ANTIMICROB. AGENTS CHEMOTHER. in normal saline, with.1 ml from appropriate dilutions spread on the surface of Mueller-Hinton agar. Resistant isolates were selected by plating.1 ml from the same saline dilutions on agar containing antibiotics. Because overnight cultures yielded only 18 CFU/ml, the population of organisms sampled for CFU/ml by incorporating 1 ml of the overnight culture in pour plates containing antibiotics (2.5 ml in four plates containing 15 ml of agar The antibiotics andconcentrations usedin plates were as follows (pg/ml): nafcillin, methicillin, and cep, each at 2 and1 rifampin, 1;, vancomycin, 2, and gentamicin, 5. These concentrations were chosen to represent levels which would be difficult to attain or maintain in patients. Plate counts were determined after 72 h of incubation, and the number of resistant isolates was determined by the ratio, CFU on plates containing antibiotics/cfu on plates without antibiotics. The fraction was converted to the negative log to indicate the resistance frequency. Antibiotic resistance was further confirmed by picking four colonies from each plate containing antibiotics, incubating them in antibiotic-free broth, and determining the MIC and MBC for each colony of the antibiotic contained in the plate. Time-kill studies. One hundred-fold dilutions of overnight cultures of S. epidermidis were added to 1 ml of Mueller-Hinton broth in 25-ml flasks. The organisms were allowed to grow for 3 h to a concentration of approximately 17 CFU oflog-phase bacteria per ml, and antibiotics were added. Flasks were incubated at 37 C with shaking for 48 h. Samples were removed and serially diluted for viable count before (zero time) and at 2, 4, 8, 24, and 48 h after the addition of antibiotics. Duplicate samples were plated at zero time and at 24 and 48 h on plain agar and on agar containing the antibiotic added to the flask; the number of resistant isolates was determined as described above. The antibiotics added to the flasks were rifampin (1 isg/ml), cephalothin (2 Ag/ml), nafcillin (2 jig/ml), or methicillin (2 jag/ml). Time-kill curves were performed at least twice for each isolate tested. RESULTS Antimicrobial susceptibility. The cumulative percentage of S. epidermidis isolates inhibited (MIC) or killed (MBC) by various antimicrobial agents is shown in Table 1. For 85% of the isolates, the MIC was :1.6 yg of penicillin G per ml; for 78%, the MIC was ug of methicillin per ml; and for 7%, the MIC was -25,ug of streptomycin per ml. There was no difference in methicillin susceptibility between isolates from patients with PVE and CSF shunt infections, nor were there differences in methicillin susceptibility among isolates from different geographic areas. Only 19% of isolates were resistant to nafcillin (MIC isg/ml) when tested in microtiter. Repeat nafcillin susceptibility testing in tubes resulted in a fourfold or greater increase in MIC in four isolates; skipped tubes and highly resistant mutants were observed on MBC testing of each of these isolates. Cefoxitin and cephradine were relatively inactive (7% of isolates for which the MICs were ug/ml). No difference in cephalothin susceptibility was detected between results obtained in microtiter and in tubes. Vancomycin Downloaded from on April 26, 218 by guest

3 VOL. 14, 1978 SUSCEPTIBILITY OF S. EPIDERMIDIS 355 e co e e l Cq el CC I e _ QRO_ CO C M U- CO U3 M M M M ko _P- XOM 2 mtb ste ec clics r4 _ clre cli o ooceodi O t - COoC. -1. C.) C.). 4). 'IO a. C.) m I t C.) ri C. I 54) is eq cs 1 C1 eq " - Olts,-1co C C*r- C* Lat-MP-4 U CD um t-cd O ~ C ' t~-~- tc cu,z]~ :3~ Ct) C t- O ffi O _ 9 9 o m oo b o X b R%5 CD OC 5U cq h W- ko CS q (O LO i C- O P-O- O DOOCq t CD to CD. 4) i eqv- CD eqeo _- _ II _It LO,-4, o o4 -Iq.O t- - - O1V _ 1 '_. COY - o-4 e t-. N (O I"1 ~ eqt~ InN o o CO _ I1 CO t- eqnf 6 4) a *1 4L) 6 1 OD Downloaded from on April 26, 218 by guest eq o vo t- 'q CO 1.4 4).,V C) j. a

4 356 ARCHER showed consistent activity, both inhibiting and killing 8% of the isolates at concentrations of 1.6 to 6.25 pg/ml. Neither nafcillin nor cephalothin gave more than a two-dilution (fourfold) difference between MIC and MBC determinations with either tube or microtiter susceptibility testing. MIC and MBC testing of nafcillin, methicillin, and cephalothin in 5% NaCl at 3 C resulted in a fourfold or greater increase in both MIC and MBC to methicillin and nafcillin for all 17 isolates later found to contain resistant subpopulations (vide infra); there was a change in susceptibility to cephalothin for only a single isolate. Although high-level resistance to streptomycin (MIC - 5 ug/ml) was seen in 65% of isolates, the newer afminoglycosides were highly active. Gentamicin at a concentration of.2 pg/ml killed 89% of isolates, whereas three isolates, two from patients with PVE and one from a patient with a CSF shunt infection, were resistant to 6.25,ug of this antibiotic per ml. Tobramycin was always at least fourfold less active against each isolate than gentamicin, and amikacin was only 1/8 to 1/16 as active as gentamicin. Clindamycin was very active against some isolates, but 25% were highly resistant (MIC 25,ug/ml). Rifampin was the most effective of all antibiotics studied; for no isolate was the MBC >.1,ug/ml. Five antibiotics which might constitute effective therapy of S. epidermidis infections were chosen for further studies on the basis of susceptibility tests reported above. These were nafcillin, cephalothin, vancomycin, gentamicin, and rifampin. Methicillin was also included for comparison. Selection for resistance. The number of solates containing highly antibiotic-resistant colonies and the frequency of occurrence of the resistant colonies are shown in Table 2. Isolates contining subpopulations resistant to 2 ug of methicillin per ml will hereafter be designated methicillin-resistant (MR); those containing no colonies resistant to 2 plg of methicillin per ml will be designated methicillin-sensitive (MS). Susceptibility testing did not uniformly identify those isolates containing highly MR subpopulations. Three isolates (11%) for which the MIC was 6.25,ug of methicillin per ml contained no colonies resistant to 2,ug of that antibiotic per ml, whereas three isolates with that MIC contained colonies resistant to 1 ug of the drug per ml. Likewise, one of four isolates for which the MIC was 12.5 pug/ml contained no resistant colonies. Each MR isolate also contained colonies resistant to 2 pig of nafcillin and cephalothin per ml, but resistance to these antibiotics ANTIMICROB. AGENTS CHEMOTHER. TABLz 2. Antibiotic resistance occurring in populations ofstaphylococcus epidermidisa Patient isolates Antibiotic wita sistant Resistance frequency colonies (%) Methicillin (2) 63 lo-4.3 *.5 Methicillin (1) 63 lo-4.8 *.5 Nafcillin (2) *.5 Nafcillin (1) 52 1lo t.8 Cephalothin (2) 63 lo-4 ±.9 Cephalothin (1) 4 lo-7.7 Rifampmn (1) 1 1o Vancomycin (2) No resistant colonies/19 Gentamicin (5) 11 Total population resistant Values in parentheses indicate concentration in micrograms per milliliter. Other values indicate ratio of resistant colonies/total colonies, and represent the mean ± standard deviation of 27 isolates tested. was expressed at a lower frequency than resistance to methicillin. Colonies resistant to 1 ug of cephalothin per ml were found in only one isolate. There were no colonies resistant to 2,ug of nafcillin or cephalothin per ml selected from any MS isolate. Every isolate contained colonies resistant to 1 ug ofrifampin per ml, and no isolate contained colonies resistant to 2,ug of vancomycin per,ml. Gentamicin resistance was uniformly expressed in those three isolates with high MICs; there were no colonies resistant to 5,ug of gentamicin per ml among gentamicin-susceptible isolates. For 92% of the colonies picked from agar containing methicillin, the MICs and MBCs were -5,g/ml. However, 24% of the colonies picked from nafcillin plates and 33% from cephalothin plates reverted to the antibiotic susceptibility of the parent strain after overnight incubation in antibiotic-free broth. Isolates remaining antibiotic resistant grew slowly, and MICs could only be read after 48 h of incubation at 37C. Emergence of resistance with time. Six MR and five MS isolates were selected for timekill studies with methicillin, nafcillin, cephalothin, and rifampin (Fig. 1). The MBCs of nafcillin, cephalothin, and rifampin were similar for MR and MS isolates:.4 to 1.6 and.2 to 1.6 pg of nafcillin per ml for MR and MS isolates, respectively;.4 to 3.12 and.2 to 1.6,g of cephalothin per ml for MR and MS isolates, respectively; and.125 to.1 pg of rifampin per ml for both MR and MS isolates. Rifampin resistance emerged in all eleven isolates studied. Early killing was rapid, but growth Downloaded from on April 26, 218 by guest

5 VOL. 14, 1978 to the same number of CFU as control occurred between 8 and 24 h. Methicillin, nafcillin, and cephalothin showed a difference in their ability to kill MR versus MS strains. MS isolates were reduced from 17 CFU to <12 CFU by 2,g of any of the three antibiotics per ml after 48 h of incubation, and none of the remaining cells were antibiotic-resistant. MR isolates were not killed by 2 ug of methicillin per ml and were incompletely killed after 24 h of incubation with 2,ug of nafcillin or cephalothin per ml. Between 24 and 48 h of incubation, MR isolates grew two logs in nafcillin, whereas organisms exposed to cephalothin remained at the same concentration (Fig. 1). A comparison of the effects of rifampin, nafcillin, methicillin, and cephalothin on the emergence of resistance after incubation of rapidly growing MR organisms with these antibiotics is shown in Table 3. Rifampin-resistant colonies, although occurring at a low frequency in the parent strain, were rapidly and completely se- Q 7 9 HOURS FIG. 1. Killing of six MR and five MS S. epidermidis isolates with antibiotics over 48 h. Antibiotic concentrations of methicillin, nafcillin, and cephalothin were 2 pg/ml, and rifampin was at 1 pg/ml. Each point represents the mean CFU per milliliter for all designated isolates tested with that antibiotic; no count varied by more than ±.8 log among the isolates at each point. SUSCEPTIBILITY OF S. EPIDERMIDIS 357 lected so that virtually all cells were resistant by 24 h. The number of nafcillin-resistant colonies, however, did not change sigificantly by 24 h, although they comprised a larger percentage of the total population; a further 24 h of incubation was required before they increased in number. No cephalothin-resistant colonies were selected after 48 h of incubation, although almost 14 viable organisms remained. Rifampin-resistant colonies, after passage in antibiotic-free broth, were not killed by 1,ug of rifampin per ml and grew in a manner similar to control when retested by time-kill methods. Nafcillin-resistant colonies, however, were killed in a manner smilar to the parent strain upon reexposure to 2,ig of the antibiotic per ml. DISCUSSION This study has demonstrated the resistance to multiple antibiotics of isolates of S. epiderinidis from documented infections of indwelling foreign devices. None of the 27 isolates was susceptible to all 18 antibiotics studied; 85% were resistant to two, and 67% were resistant to six or more antibiotics. Resistance was defined as an MIC higher than concentrations which could be easily achieved in vivo, or -1.6,ug of penicillin G per ml. Studies of isolates of S. epidermidis from the clinical laboratory show a greater degree of antibiotic susceptibility than was demonstrated with known pathogenic isolates in this study (3, 12). However, susceptibility data reported for isolates of S. epidermidis from cases of PVE confirm their resistance to methicillin and other antistaphylococcal antibiotics (7). Resistance to methicillin as defined by the growth of colonies on agar containing 2 utg of the antibiotic per ml was found in 63% of isolates in this study. This is in contrast to reported incidences of methicillin resistance in 1 to 33% of isolates from clinical laboratories by disc or agar dilution susceptibility testing (11, 15). Methicillin resistance in S. aureus has been extensively studied and defined as intrinic or not due to enzymatic destruction of the antibiotic (17). Characteristics of S. aureus methicillin re- Downloaded from on April 26, 218 by guest TABLE 3. Selection of antibiotic resistance after the addition of antibiotics to growing cultures ofsix MR S. epidermidis isolateea Total CFU at: Resistant CFU at: Antibiotic Oh 24h 48h Oh 24h 48h Methicillin (2) 1i6-8 ± i.7 7. *.6 1o3.5 ± * Nafcilin (2) lo6. * lo5.9 * 1. 1o2.3 ±.2 1o2.5 ±.5 lo6." ± 1.2 Cephalothin (2) 17. ±.3 1o ±.6 2 ± 1 <1 <1 Rifampin (1) 16.8 ± ± <1 164 * 1.2 1o8o *.4 Values in parentheses indicate concentration in micrograms per milliliter. All other values represent mean istandard deviation.

6 358 ARCHER ANTIMICROB. AGENTS CHEMOTHER. sistance were found among the S. epidernidis mase production was found in all penicillin-reisolates in this study. These included the follow- sistant isolates (those for which the MIC was ing: the MR phenotype was heterogeneic, found -1.6,ug of penicillin G per ml [G. Archer and S. in only 1 cell in 14 at 37C; resistant cells were Markowitz, unpublished observations]), the neither inhibited nor killed by 1 jig of methi- characteristics of enzyme-mediated antibiotic cillin per ml; and resistant cells grew slowly at resistance were not seen among MR isolates. 37C. All MR isolates also contained colonies That is, the frequency ofoccurrence ofresistance resistant to 2,ug of nafcillin per ml. The resist- was too low in the population, and the rate of ance characteristics were similar to those of growth of resistant colonies was too slow to be methicillin, although the phenotypic expression typical of f8-lactamase-mediated resistance (13). of nafcillin resistance occurred at a lower fre- Tolerance, a recently described resistance to quency than did methicillin resistance. cell-wall-active antibiotics among S. aureus, also The detection of methicillin and nafcillin re- did not seem to be an important resistance sistance was not always possible on the basis of mechanism. This form of resistance is charactermicrotiter twofold dilution susceptibility tests at ized by the inhibition of bacterial growth withthe standard inoculum of 15 CFU/ml. Of six out bacterial killing (low MIC, high MBC), and isolates for which the MIC was 6.25 /Ag of meth- resistance is lost after prolonged storage or with icillin per ml, only one-half contained a highly prolonged incubation timne (13). A difference beresistant subpopulation; one of four isolates for tween the MICs and MBCs of nafcillin for our which the MIC was 12.5 jig of methicillin per ml isolates was not seen by either microtiter or contained no resistant cells. Likewise, although tube-dilution testing, nor did fresh clinical isoall MR isolates contained nafcillin-resistant lates exhibit the phenomenon. cells, the MIC for only 4 of 17 (15%) MR isolates Two of the cephalosporin antibiotics tested was >3.12,Lg of nafcillin per ml. The small (cephalothin and cefamandole) had excellent acnumber of bacteria in each microtiter well (15 tivity against most S. epidernidis isolates, one CFU/ml x.2 ml) is obviously too low to detect (cefazolin) had intermediate activity, and one nafcillin resistance which occurs with a low fre- (cephradine) had poor activity. Cefoxitin, a new quency. However, the use of the standard tube cephamycin derivative, was also inactive against dilution susceptibility test and a larger inoculum most isolates. Colonie to 2 ug of ceph- (5 x 1 CFU/ml x 1. ml) detected nafcillin- t d Mthe qey resistant subpopulations in only four additional isolates. was v 14 Unlike resistance to semi- The use of hypertonic media (5% NaCl), low esyntheic penic, resistance to cephalothin incubation temperature (3C), and prolonged could not be detected by changing inoculum size incubation time (48 h) increased the MIC of or physical factors during susceptibility testing. nafcillin and methicillin for all isolates found to Furthermore, cephalothin-resistant subpopulacontain resistant colonies. These factors have tions did not emerge during 48 h of incubation been shown to increase the subpopulations in S. of MR isolates with 2,ug of the antibiotic per aureus resistant to semisynthetic penicillins and ml, although killing was incomplete. The perto enhance their phenotypic expression (2, 17). sistence of cephalothin-susceptible colonies The importance of identifying isolates contain- among MR isolates after 24 to 48 h of incubation ing subpopulations resistant to nafcillin and may be. partially explained by a decrease in methicillin was shown by time-kill studies. Pop- cephalothin concentration in Mueller-Hinton ulations totally resistant to nafcillin and methi- broth of up to 8% after 24 h of incubation at cillin emerged after 48 h of exposure to either 37C (G. Archer, unpublished observations). drug among MR isolates; killing was almost com- However, this does not explain the difference in plete, and no resistant cells emerged among MS killing between MR and MS isolates; further isolates. The use of large inocula to overcome studies are needed to explain this discrepancy. the inoculum effect produced by the low phe- Laverdiere et al. (1) recently confirmed the notypic expression of a resistant trait and the absence of complete cross-resistance between alteration of physical and chemical factors in methicillin and cephalosporins against MR S. order to enhance the detection of resistance epidermidis isolates from a variety of sources. should be routinely employed to identify S. ep- However, whereas only 47% of the isolates from idermidis isolates from serious infections which their study were killed by s6.25 jig of cephaloare resistant to semisynthetic penicillins. thin per ml, 76% (13 of 17) of the MR isolates in Mechanisms of resistance to semisynthetic our study were killed by this concentration of penicillins among S. epidermidis other than in- cephalothin. Thus, on the basis of our data, trinsic resistance were not identified in this cephalothin, cefazolin, and cefamandole appear study. Although methicillin-inducible /3-lacta- to be superior to semisynthetic penicillins for Downloaded from on April 26, 218 by guest

7 VOL. 14, 1978 initial therapy of serious S. epidermidis infections. Rifampin was the single most active antibiotic against S. epidernidis; the MBC for no isolate was >.1,ug/ml. However, resistant cells, although occurring at a low frequency (1-72), were found in every isolate. In contrast to resistance to semisynthetic penicillins, rifampin resistance was rapidly selected, resistant cells grew at a normal rate, and the resistant phenotype was stable and homogenous in the population after selection. Resistance to rifampin has been shown to be due to a one-step mutation whereby the target enzyme, ribonucleic acid polymerase, no longer binds the antibiotic (4). However, because of the uniformly high susceptibility of the majority population of S. epidermidis to rifampin, the demonstration that the addition of a second antibiotic can prevent the emergence of rifampin resistance (1), and the successful use of rifampin-containing regimens to treat serious infections caused by MR S. aureus (8), rifampin should be considered a potentially useful antibiotic for the treatment of serious S. epidermidis infections. Vancomycin and gentamicin may also be valuable antibiotics for the treatment of infections caused by S. epidermidis. Although isolates had only internediate susceptibility to vancomycin, no resistant subpopulations were found. This antibiotic is of proven value in the treatment of severe infections caused by S. aureus (6). Gentamicin-susceptible isolates had the lowest MICs and MBCs for this antibiotic of any of the drugs studied, and they were at least fourfold lower than for the other available newer aminoglycosides (tobramycin and amikacin). No resistant subpopulations were found, and the three resistant isolates were easily identified by routine susceptibility testing. This resistance may be plasmid-mediated, as has been described for S. aureus (16). The therapy of S. epidernidis infections of indwelling foreign devices should be carefully guided by antimicrobial susceptibility tests. However, routine tests for resistance to semisynthetic penicillins may be misleading, and these antibiotics should not be used as initial therapy. Antibiotic combinations chosen from the cephalosporins, vancomycin, gentamicin, and rifampin may improve the cure of these refractory infections. More studies are necessary to define resistance mechanisms among S. epidernidis. ACKNOWLEDGMENTS I am grateful to J. Linda Johnston for her excellent technical assistance and to Sheldon Markowitz for his review of SUSCEPTIBILITY OF S. EPIDERMIDIS 359 the manuscript. This work was supported by Public Health Service grant number 5 RO 1 HL from the National Heart, Lung, and Blood Institute. LITERATURE CITED 1. Arioli, V., M. Berti, G. Carniti, E. Rossi, and L. G. Silvestri Interaction between rifampin and trimethoprim in vitro and in experimental infections. J. Antimicrob. Chemother. 3: Barry, A. L., and R. E. Badal Reliability of the microdilution technic for the detection of methicillinresistant strains of Staphylococcus aureus. Am. J. Clin. Pathol. 67: Corse, J., and R. E.. Williams Antibiotic resistance of coagulase-negative staphylococci and micrococci. J. Clin. Pathol. 21: di Mauro, D., L. Snyder, P. Marino, A. Lamberti, A. Coppo, and G. P. Tocchini-Valentini Rifampicin sensitivity of the components of DNA-dependent RNA polymerase. Nature (London) 222: Dismukes, W. E., A. W. Karchmer, M. J. Buckley, W. G. Austen, and M. N. Swartz Prosthetic valve endocarditis: analysis of 38 cases. Circulation 48: Esposito, A. L, and R. A. Gluckman Vancomycin: a second look. J. Am. Med. Assoc. 238: Johnson, W. D Prosthetic valve endocarditis p In D. Kaye (ed.), Infective endocarditis. University Park Press, Baltimore. 8. Jensen, K Methicillin-resistant staphylococci. Lancet ii: Keys, T. F., and W. L. Hewitt Endocarditis due to micrococci and Staphylococcus epidermidis. Arch. Intern. Med. 132: Laverdiere, M., P. K. Peterson, J. Verhoef, D. N. Williams, and L D. Sabath In vitro activity of cephalosporins against methiciflin-resistant, coagulasenegative staphylococci. J. Infect. Dis. 137: Sabath, L D., F. F. Barrett, C. Wilcox, D. A. Gerstein, and M. Finland Methicillin resistance of Staphylococcus aureus and Staphylococcus epidermidis, p Antinicrob. Agents Chemother Sabath, L. D., C. Garner, C. Wilcox, and M. Finland Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob. Agents Chemother. 9: Sabath, L D., N. Wheeler, M. Laverdiere, D. Blazevic, and B. J. Wilkinson A new type of penicillin resistance of Staphylococcus aureus. Lancet i: Schoenbaum, S. C., P. Gardner, and J. Shillito Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J. Infect. Dis. 131: Slaughter, L., J. E. Morris, and A. Starr Prosthetic valvular endocarditis: a 12-year review. Circulation 47: Smith, H. B. H., and H. Farkas-Himsley The relationship of pathogenic coagulase-negative staphylococci to Staphylococcus aureus. Can. J. Microbiol. 15: Sutherland, R., and G. N. Rolinson Characteristics of methicillin-resistant staphylococci. J. Bacteriol. 87: Wood, D. O., M. J. Carter, and G. K. Best Plasmid-mediated resistance to gentamicin in Staphylococcus aureus. Antimicrob. Agents Chemother. 12: Downloaded from on April 26, 218 by guest

Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis

Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 1979, p. 655-659 0066-4804/79/11-0655/05$02.00/0 Vol. 16, No. 5 Susceptibility and Synergy Studies of Methicillin-Resistant Staphylococcus epidermidis MICHAEL

More information

Methicillin-Resistant, Coagulase-Negative Staphylococci:

Methicillin-Resistant, Coagulase-Negative Staphylococci: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 90, p. 79-3 0066-0/0/0-079/05$0.00/0 Vol. 7, No. Activity of Cephalosporins Against Methicillin-Susceptible and Methicillin-Resistant, Coagulase-Negative Staphylococci:

More information

Evaluation of MicroScan MIC Panels for Detection of

Evaluation of MicroScan MIC Panels for Detection of JOURNAL OF CLINICAL MICROBIOLOGY, May 1988, p. 816-820 Vol. 26, No. 5 0095-1137/88/050816-05$02.00/0 Copyright 1988, American Society for Microbiology Evaluation of MicroScan MIC Panels for Detection of

More information

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Jan. 1977, p. 126-131 Copyright X 1977 American Society for Microbiology Vol. 11, No. 1 Printed in U.S.A. In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

More information

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Journal of Antimicrobial Chemotherapy (78) 4, 53-543 Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci Chatrchal Watanakunakoni and Cheryl Glotzbecker Infectious

More information

against Clinical Isolates of Gram-Positive Bacteria

against Clinical Isolates of Gram-Positive Bacteria ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,

More information

Aminoglycoside-resistant enterococci

Aminoglycoside-resistant enterococci Aminoglycoside-resistant enterococci M. J. BASKER, B. SLOCOMBE, AND R. SUTHERLAND From Beecham Pharmaceuticals Research Division, Brockham Park, Betchworth, Surrey J. clin. Path., 1977, 30, 375-380 SUMMARY

More information

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae ANTIMICROBIAL AGzNTS AND CHEMOTHERAPY, Oct. 1976, P. 592-597 Copyright 1976 American Society for Microbiology Vol. 1, No. 4 Printed in U.S.A. Comparative Activity of Netilmicin, Gentamicin, Amikacin, and

More information

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 2000, p. 1062 1066 Vol. 44, No. 4 0066-4804/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. In Vitro Activities of Daptomycin,

More information

Susceptibility Tests for Methicillin-Resistant (Heteroresistant) Staphylococci

Susceptibility Tests for Methicillin-Resistant (Heteroresistant) Staphylococci JOURNAL OF CLNCAL MCROBOLOGY, Apr. 1984, p. 482-488 95-1137/84/4482-7$2./ Copyright C) 1984, American Society for Microbiology Vol. 19, No. 4 New Recommendations for Disk Diffusion Antimicrobial Susceptibility

More information

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain

More information

Tel: Fax:

Tel: Fax: CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.

More information

Resistance of Coagulase-Positive Staphylococci

Resistance of Coagulase-Positive Staphylococci JOURNALOF BACrERIOLOGY, Apr., 1965 Copyright a 1965 American Society for Microbiology Vol. 89, No. 4 Printed in U.S.A. Resistance of Coagulase-Positive Staphylococci to Methicillin and Oxacillin CHARLES

More information

of Staphylococcus aureus

of Staphylococcus aureus APPLIED MICROBTOLOGY, Dec. 97, p. -7 Copyright ( 97 American Society for Microbiology Vol., No. 6. Printed in U.S.A. Bacteriophage Types and Antibiotic Susceptibility of Staphylococcus aureus J. KLASTERSKY,

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

Determination of antibiotic sensitivities by the

Determination of antibiotic sensitivities by the Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,

More information

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck

Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck Quality Control Testing with the Disk Antibiotic Susceptibility Test of Bauer-Kirby-Sherris-Turck DONNA J. BLAZEVIC, M.P.H., MARILYN H. KOEPCKE, B.S., A JOHN M. MATSEN, M.D. Departments of Laboratory Medicine

More information

Pharmacological Evaluation of Amikacin in Neonates

Pharmacological Evaluation of Amikacin in Neonates ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUlY 1975, p. 86-90 Copyright 0 1975 American Society for Microbiology Vol. 8, No. 1 Printed in U.SA. Pharmacological Evaluation of Amikacin in Neonates JORGE B.

More information

Acquired and Native Resistance of Staphylococcus

Acquired and Native Resistance of Staphylococcus APPLED MCROBOLOGY, JUlY 1970, p. 1-5 Copyright 1970 American Society for Microbiology Vol. 20, No.1 Printed in U.S.A. Acquired and Native Resistance of Staphylococcus aureus to Cephalexin and Other f3-lactam

More information

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System

Evaluation of the BIOGRAM Antimicrobial Susceptibility Test System JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1985, p. 793-798 0095-1137/85/110793-06$02.00/0 Copyright 1985, American Society for Microbiology Vol. 22, No. 5 Evaluation of the BIOGRAM Antimicrobial Susceptibility

More information

Staphylococcus aureus with the Disc

Staphylococcus aureus with the Disc ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1972, p. 422-426 Vol. 1, No. 5 Copyright 1972 American Society for Microbiology Printed in U.S.A. Identification of Cephalosporin-Resistant Staphylococcus aureus

More information

Susceptibility of Staphylococcus aureus to

Susceptibility of Staphylococcus aureus to ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1973, p. 263-269 Copyright 0 1973 American Society for Microbiology Vol. 4, No. 3 Printed in U.S.A. Effect of Temperature on the In Vitro Susceptibility of

More information

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory ANTimICROBIAL AGENTh AND CHEMOTHERAPY, OCt. 1976, p. 677-681 Copyright 1976 American Society for Microbiology Vol. 10, No. 4 Printed in U.S.A. In Vitro Susceptibility of Gentamicin-Resistant Enterobacteriaceae

More information

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time) Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according

More information

NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE. J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE and G. H.

NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE. J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE and G. H. 46 THE JOURNAL OF ANTIBIOTICS APR. 1976 NAFCILLIN AND OXACILLIN COMPARATIVE ANTISTAPHYLOCOCCAL ACTIVITY IN MICE J. A. YURCHENCO, M. W. HOPPER, T. D. VINCE a G. H. WARREN Research Division, Wyeth Laboratories,

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

Antibiotic Susceptibility of Pseudomonas aeruginosa

Antibiotic Susceptibility of Pseudomonas aeruginosa ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1978, p. 979-984 0066-4804/78/0013-0979$02.00/0 Copyright ) 1978 American Society for Microbiology Vol. 13, No. 6 Printed in U.S.A. Effect of Triethylenetetramine

More information

Disk Susceptibility Studies with Cefazolin and Cephalothin

Disk Susceptibility Studies with Cefazolin and Cephalothin ANTIMICROBiAL AGENTS AND CHEMOTHEMRAPY, Jan. 1974, p. 63-67 Copyright i 1974 American Society for Microbiology Vol. 5, No. 1 Printed in U.SA. Disk Susceptibility Studies with Cefazolin and Cephalothin

More information

In Vitro Susceptibility of Brucella

In Vitro Susceptibility of Brucella APPuED MICROBIOLOGY, Oct. 1970, p. 600-604 Vol. 20, No. 4 Copyright 1970 American Society for Microbiology Printed in U.S.A. In Vitro Susceptibility of Brucella to Various Antibiotics WENDELL H. HALL AND

More information

Susceptibility of Staphylococcus aureus and Staphylococcus

Susceptibility of Staphylococcus aureus and Staphylococcus ANTIMICROBIAL AGENTS AND CHaMoTHRLY, June 1976, p. 962-969 Copyright 1976 American Society for Microbiology Vol. 9, No. 6 Printed in USA. Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis

More information

Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital

Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a tertiary care hospital ISSN: 2319-7706 Volume 3 Number 9 (2014) pp. 689-694 http://www.ijcmas.com Original Research Article Detection of inducible clindamycin resistance among clinical isolates of Staphylococcus aureus in a

More information

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.

More information

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Int.J.Curr.Microbiol.App.Sci (2018) 7(8): International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 08 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.708.378

More information

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and

Ciprofloxacin, Enoxacin, and Ofloxacin against Aerobic and ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1988, p. 1143-1148 Vol., No. 8 0066-4804/88/081143-06$00/0 Copyright 1988, American Society for Microbiology Comparative Activities of, Amoxicillin-Clavulanic

More information

Factors affecting plate assay of gentamicin

Factors affecting plate assay of gentamicin Journal of Antimicrobial Chemotherapy (1977) 3, 17-23 Factors affecting plate assay of gentamicin II. Media D. C. Shanson* and C. J. Hince Department of Medical Microbiology, The London Hospital Medical

More information

Principles of Antimicrobial Therapy

Principles of Antimicrobial Therapy Principles of Antimicrobial Therapy Doo Ryeon Chung, MD, PhD Professor of Medicine, Division of Infectious Diseases Director, Infection Control Office SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE CASE 1

More information

Studies on Antibiotic Synergism Against Enterococci

Studies on Antibiotic Synergism Against Enterococci Studies on Antibiotic Synergism Against Enterococci II. EFFECT OF VARIOUS ANTIBIOTICS ON THE UPTAKE OF 4C-LABELED STREPTOMYCIN BY ENTEROCOCCI ROBERT C. MOELLERING, JR. and ARNOLD N. WEINBERG From the Infectious

More information

Eradicating Carrier State of Methicillin-Resistant Staphylococcus

Eradicating Carrier State of Methicillin-Resistant Staphylococcus ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Sept. 1990, p. 1655-1659 0066-4804/90/091655-05$02.00/0 Copyright 1990, American Society for Microbiology Vol. 34, No. 9 Efficacy of Short Courses of Oral Novobiocin-Rifampin

More information

SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS

SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS Thorax (195), 5, 162. THE BEHAVIOUR OF MIXTURES OF STREPTOMYCIN- SENSITIVE AND -RESISTANT TUBERCLE BACILLI IN LIQUID MEDIUM SENSITIVITY TESTS BY D. A. MITCHISON* From the Department of Bacteriology, Postgraduate

More information

Effeet on Bacterial Growth

Effeet on Bacterial Growth ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 17, p. 36-366 Copyright ( 17 American Society for Microbiology Vol., No. 5 Printed in U.S.A. Automatic Radiometric Measurement of Antibiotic Effeet on Bacterial

More information

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1987, p. 546-550 0095-1137/87/030546-05$02.00/0 Copyright C 1987, American Society for Microbiology Vol. 25, No. 3 Evaluation of the AutoMicrobic System for Susceptibility

More information

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING Pages with reference to book, From 94 To 97 S. Hafiz, N. Lyall, S. Punjwani, Shahida Q. Zaidi ( Department of Microbiology, The Aga Khan University

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Antibacterial susceptibility testing

Antibacterial susceptibility testing Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several

More information

Synergism, Killing Kinetics, and Antimicrobial Susceptibility

Synergism, Killing Kinetics, and Antimicrobial Susceptibility ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 1981, p. 716-725 0066-4804/81/050716-10$02.00/0 Vol. 19, No. 5 Synergism, Killing Kinetics, and Antimicrobial Susceptibility of Group A and B Streptococci C.

More information

Resistance to cloxacillin among hospital staphylococci.

Resistance to cloxacillin among hospital staphylococci. J. clin. Path. (1967). 87 Resistance to cloxacillin among hospital staphylococci. G. C. TURNER' AND P. E. COX From the Department of Pathology, Sefton General Hospital, Liverpool SYNOPSIS Cloxacillin-resistant

More information

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects

Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p. 35 39 Vol. 40, No. 1 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa

More information

Reassessment of the "Class" Concept of Disk Susceptibility Testing

Reassessment of the Class Concept of Disk Susceptibility Testing Reassessment of the "Class" Concept of Disk Susceptibility Testing Disks versus Minimal Inhibitory Concentrations with Eleven Cephalosporins ARTHUR L. BARRY, PH.D., CLYDE THORNSBERRY, PH.D., RONALD N.

More information

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital

Detection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415

More information

Susceptibility Testing

Susceptibility Testing APPLIED MICROBIOLOGY, Nov. 1969, p. 766-770 Copyright 1969 American Society for Microbiology Vol. 18, No. 5 Printed in U.S.A. Effect of Mixed Cultures on Antibiotic Susceptibility Testing AZRA SHAHIDI

More information

by adding different antibiotics to sera containing

by adding different antibiotics to sera containing J. clin. Path., 1977, 30, 521-525 Serum gentamicin assays of 100 clinical serum samples by a rapid 40 C Kiebsiella method compared with overnight plate diffusion and acetyltransferase assays D. C. SHANSONI

More information

Introduction to Pharmacokinetics and Pharmacodynamics

Introduction to Pharmacokinetics and Pharmacodynamics Introduction to Pharmacokinetics and Pharmacodynamics Diane M. Cappelletty, Pharm.D. Assistant Professor of Pharmacy Practice Wayne State University August, 2001 Vocabulary Clearance Renal elimination:

More information

Synergy Between Cephalosporin and Aminoglycoside

Synergy Between Cephalosporin and Aminoglycoside ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 1974, P. 571--577 Copyright 0 1974 American Society for Microbiology Vol. 5, No. 6 Printed in U.S.A. Synergy Between Cephalosporin and Aminoglycoside Antibiotics

More information

Improved Susceptibility Disk Assay Method Employing an

Improved Susceptibility Disk Assay Method Employing an ANTIMICROIAL AGENTS AND CHEMOTHERAPY, Nov. 1978, P. 761-764 66-484/78/14-761$2./ pyright 1978 American Society for Microbiology Vol. 14, No. 5 Printed in U.S.A. Improved Susceptibility Disk Assay Method

More information

D-Lactic Acid Production as a Monitor of the Effectiveness

D-Lactic Acid Production as a Monitor of the Effectiveness ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 1991, p. 237-241 Vol. 35, No. 2 0066-4804/91/020237-05$02.00/0 Copyright 1991, American Society for Microbiology D-Lactic Acid Production as a Monitor of the

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae

Brief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot

More information

Staphylococcus aureus

Staphylococcus aureus J. clin. Path., 197, 23, 19-23 Stability of neomycin resistance in Staphylococcus aureus G. A. J. AYLIFFE From the Hospital Infection Research Laboratory, Summerfield Hospital, Birmingham SYNOPSIS A strain

More information

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016 Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that

More information

Penicillinase-Resistant Penicillins and Cephalosporins

Penicillinase-Resistant Penicillins and Cephalosporins JOURNAL OF CLINICAL MICROBIOLOGY, May 1986, p. 832-839 0095-1137/86/050832-08$02.00/0 Copyright C 1986, American Society for Microbiology Vol. 23, No. 5 The Role of 13-Lactamase in Staphylococcal Resistance

More information

certain antimicrobial agents (8, 12). The commercial availability

certain antimicrobial agents (8, 12). The commercial availability ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1987, p. 1579-1584 Vol. 31, No. 10 0066-4804/87/101579-06$02.00/0 Copyright 1987, American Society for Microbiology Broth Microdilution Testing of Susceptibilities

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

Acquisition of antibiotic resistance by

Acquisition of antibiotic resistance by Acquisition of antibiotic resistance by Staphylococcus aureus in skin patients JAY NAIDOO AND W. C. NOBLE Journal of Clinical Pathology, 1978, 31, 1187-1192 From the Department of Bacteriology, Institute

More information

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017 Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,

More information

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.1 INTRODUCTION Microorganisms that cause infectious disease are called pathogenic microbes. Although

More information

RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN

RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN Hussein Azzam Bataineh 1 ABSTRACT Background: Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #407: Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES:

More information

University, New York, New York Received for publication 7 May was measured by the broth dilution method as previously

University, New York, New York Received for publication 7 May was measured by the broth dilution method as previously ANTmIcaoBIAL AGuNTS AND CHUMTrHURAPY, Sept. 1976, p. 526-534 Copyright C 1976 American Society for Microbiology Vol. 10, No. 3 Printed in U.S.A. In Vitro Study of Netilmicin Compared with Other Aminoglycosides

More information

Comparison of tablets and paper discs for antibiotic sensitivity testing

Comparison of tablets and paper discs for antibiotic sensitivity testing J. clin. Path., 1975, 28, 983-988 Comparison of tablets and paper discs for antibiotic sensitivity testing D. F. J. BROWN' AND D. KOTHARI From the Division of Hospital Infection, Clinical Research Centre,

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice

Effects of Minocycline and Other Antibiotics on Fusobacterium necrophorum Infections in Mice ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Apr. 1975, p. 421-425 Copyright 0 1975 American Society for Microbiology Vol. 7, No. 4 Printed in U.S.A. Effects of Minocycline and Other s on Fusobacterium necrophorum

More information

Randall Singer, DVM, MPVM, PhD

Randall Singer, DVM, MPVM, PhD ANTIBIOTIC RESISTANCE Randall Singer, DVM, MPVM, PhD Associate Professor of Epidemiology Department of Veterinary and Biomedical Sciences University of Minnesota Overview How does resistance develop? What

More information

Original Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e.

Original Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e. Iranian Journal of Pharmaceutical Research (22), (2): 559-563 Received: January 2 Accepted: June 2 Copyright 22 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants Study Title Antibacterial Activity and Efficacy of E-Mist Innovations' Electrostatic Sprayer Product with Multiple Disinfectants Method Modified Association of Analytical Communities Method 961.02 Modified

More information

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology Zeina Alkudmani Chemotherapy Definitions The use of any chemical (drug) to treat any disease or condition. Chemotherapeutic Agent Any drug

More information

Emergence of Gentamicin- and Carbenicillin-Resistant Pseudomonas aeruginosa in a Hospital Environment

Emergence of Gentamicin- and Carbenicillin-Resistant Pseudomonas aeruginosa in a Hospital Environment ANTImICROBsuL AGENTS AND CHEMOTHERAPY, Mar. 1976, p. 474-48 Copyright 1976 American Society for Microbiology Vol. 9, No. 3 Printed in U.S.A. Emergence of Gentamicin- and Carbenicillin-Resistant Pseudomonas

More information

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin ANTIBIOTICS USED FOR RESISTACE BACTERIA 1. Vancomicin Vancomycin is used to treat infections caused by bacteria. It belongs to the family of medicines called antibiotics. Vancomycin works by killing bacteria

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods J Clin Pathol 1984;37:159-165 Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods JJS SNELL, MVS DANVERS, PS GARDNER From the Division of Microbiological Reagents and

More information

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD

More information

New Method for Antibiotic Susceptibility Testing

New Method for Antibiotic Susceptibility Testing ANTIMIROBIAL AGENTS AND HEMOTHERAPY, Aug. 1972, p. 51-56 opyright 1972 American Society for Microbiology Vol. 2, No. 2 Printed in U.S.A. New Method for Antibiotic Susceptibility Testing G. N. ROLINSON

More information

THE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University.

THE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University. THE STABILITY OF E1VROFLOXA CIN A Senior Thesis By Meagan A. Dodge 1997-98 University Undergraduate Research Fellow Texas ASM University Group: Biology THE STABILITY OF ENROFLOXACIN MEAGANA, DODGE Submitted

More information

Disk Diffusion Susceptibility Testing of Branhamella catarrhalis

Disk Diffusion Susceptibility Testing of Branhamella catarrhalis ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 1987, p. 1519-1523 Vol. 31, No. 10 0066-4804/87/101519-05$00/0 Copyright 1987, American Society for Microbiology Disk Diffusion Susceptibility Testing of Branhamella

More information

with Other Orally Administered Drugs

with Other Orally Administered Drugs ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1983, p. 209-215 0066-4804/83/080209-07$00/0 Copyright C 1983, American Society for Microbiology Vol. 24, No. 2 In Vitro Evaluation of Three New Macrolide Antimicrobial

More information

Discrepancy Between Carbenicillin and Ampicillin Activities Against Enterococci and Listeria

Discrepancy Between Carbenicillin and Ampicillin Activities Against Enterococci and Listeria ANTMCROBAL AGENTS AND CHEMOTHEAPY, Mar. 193, p. 3339 Copyright 193 American Society for Microbiology Vol. 3, No. 3 Printed in U.S.A. Discrepancy Between Carbenicillin and Ampicillin Activities Against

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

MRSA surveillance 2014: Poultry

MRSA surveillance 2014: Poultry Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity

More information

Staphylococcus aureus

Staphylococcus aureus ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 1987, p. 1982-1988 66-484/87/121982-7$2./ Copyright 1987, American Society for Microbiology Vol. 31, No. 12 Effect of NaCl and Nafcillin on Penicillin-Binding

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA

More information

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion

More information

Lactose-Fermenting Bacteria Isolated from

Lactose-Fermenting Bacteria Isolated from APPuE MICROBIOLOGY, Nov. 969, p. 98-94 VoL 8, No. 5 Copyright 969 American Society for Microbiology Printed in U.S.A. Incidence of Infectious Drug Resistance Among Lactose-Fermenting Bacteria Isolated

More information

STAPHYLOCOCCI: KEY AST CHALLENGES

STAPHYLOCOCCI: KEY AST CHALLENGES Romney Humphries, PhD D(ABMM) Section Chief, UCLA Clinical Microbiology Los Angeles CA rhumphries@mednet.ucla.edu STAPHYLOCOCCI: KEY AST CHALLENGES THE CHALLENGES detection of penicillin resistance detection

More information

Bactericidal and Bacteriostatic Action of Chloramphenicol

Bactericidal and Bacteriostatic Action of Chloramphenicol ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUly 1979, p. 13-18 66-484/79/7-13/6$2./ Vol. 16, No. 1 Bactericidal and Bacteriostatic Action of Chloramphenicol Against Meningeal Pathogens JAMES J. RAHAL, JR.,'*

More information

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants. C. difficile rarely causes problems, either in healthy adults or in infants.

More information

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996

PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996 PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY

More information

Defining Resistance and Susceptibility: What S, I, and R Mean to You

Defining Resistance and Susceptibility: What S, I, and R Mean to You Defining Resistance and Susceptibility: What S, I, and R Mean to You Michael D. Apley, DVM, PhD, DACVCP Department of Clinical Sciences College of Veterinary Medicine Kansas State University Susceptible

More information